UnknownPhase 2NCT00471510

Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Neosil, Inc.
Principal Investigator
Johannes Gassmueller, MD
bioskin Institute for Dermatological Research and Development GmbH
Intervention
tetrapeptide aldehyde proteasome inhibitor (NEOSH101)(drug)
Enrollment
140 enrolled
Eligibility
18-49 years · MALE
Timeline
2007

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00471510 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials